-
Ombitasvir is an
antiviral drug for the
treatment of
hepatitis C
virus (HCV)
infection by AbbVie. In the
United States, it is
approved by the Food and...
-
Ombitasvir/paritaprevir/ritonavir, sold
under the
brand name
Technivie among others, is a
medication used to
treat hepatitis C. It is a fixed-dose combination...
-
hepatitis C. It is
often used
together with the
combination medication ombitasvir/paritaprevir/ritonavir
specifically for
hepatitis C
virus (HCV) type 1...
-
combination of hydrocodone/acetaminophen with the
antiviral regimen of
ombitasvir, paritaprevir, ritonavir, and
dasabuvir for
treatment of
hepatitis C increased...
- or sofosbuvir/velpatasvir.
Alternative regimens include 12 w****s of
ombitasvir/paritaprevir/ritonavir with
dasabuvir or 12 w****s of
sofosbuvir with either...
-
ritonavir as a CYP3A
inhibitor is also seen in the
Hepatitis C
medication ombitasvir/paritaprevir/ritonavir. When
administered at the
initially tested higher...
- Lumacaftor/ivacaftor
Vertex Pharmaceuticals cystic fibrosis with CFTR F508del
mutation Ombitasvir/paritaprevir/ritonavir
AbbVie Hepatitis C
Uridine triacetate Wellstat...
-
original (PDF) on 29
April 2014.
Retrieved 28
April 2014. "TECHNIVIE™ (
ombitasvir,
paritaprevir and ritonavir) Tablets, for Oral Use. Full
Prescribing Information"...
-
Sofosbuvir and
ledipasvir J05AP52 Dasabuvir,
ombitasvir,
paritaprevir and
ritonavir J05AP53
Ombitasvir,
paritaprevir and
ritonavir J05AP54
Elbasvir and...
-
generations of NS5A inhibitors,
including ledipasvir,
daclatasvir and
ombitasvir.
Because this drug
combination has the
additional quality of
being hepatically...
